Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial

https://doi.org/10.1016/0376-8716(96)01225-2Get rights and content
Under a Creative Commons license
open archive

Abstract

A 4-week, double-blind, placebo-controlled trial of amantadine was conducted in 61 cocaine dependent outpatients. Subjects received 100 mg of amantadine 3 times daily. A follow-up visit was conducted at week 8. There were no significant differences between groups in treatment retention, or in the number of benzoylecgonine positive urine samples. Self-reported drug and alcohol use declined in both groups. At week 8 follow-up, self-reported drug use was significantly lower in the placebo group. Amantadine was not effective, and discontinuation of it may have been associated with an increase in cocaine use.

Keywords

Amantadine hydrochloride
Cocaine
Double-blind outpatient
Withdrawal

Cited by (0)